Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05904106
Title Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML (VINCENT)
Acronym VINCENT
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Technische Universitat Dresden
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Essen Essen NRW 45147 Germany Details
Universitätsklinikum Aachen Aachen 52074 Germany Details
Universitätsklinikum Augsburg Augsburg 86156 Germany Details
Klinikum Chemnitz gGmbH Chemnitz 09116 Germany Details
Universitätsklinikum Dresden Dresden 01307 Germany Details
Universitätsklinikum Erlangen Erlangen 91054 Germany Details
Johann Wolfgang Goethe-Universität Frankfurt am Main 60590 Germany Details
Universitätsklinikum Halle Halle 06120 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Universitätsklinikum Schleswig-Holstein Kiel 24105 Germany Details
Universiätsklinikum Köln Köln 50937 Germany Details
Universitätsklinikum Leipzig Leipzig 04103 Germany Details
Klinikum Mannheim gGmbH Mannheim 68167 Germany Details
Philipps-Universität Marburg Fachbereich Medizin Marburg 35043 Germany Details
Universitätsklinikum Münster Münster 48149 Germany Details
Klinikum Nürnberg-Nord Nürnberg 90419 Germany Details
Krankenhaus Barmherzige Brüder Regensburg 93049 Germany Details
Robert-Bosch-Krankenhaus Stuttgart 70376 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field